{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-23-128923","form_type":"8-K","ticker":"LAB","cik":"0001162194","company_name":"STANDARD BIOTOOLS INC.","filed_at":"2023-12-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.363337+00:00","generated_at":"2026-06-07T07:13:45.405895+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"ISS recommends Standard BioTools stockholders vote for merger with SomaLogic","bullets":["ISS recommends voting 'FOR' all proposals at Special Meeting on January 4, 2024.","Merger expected to close in Q1 2024, subject to shareholder approvals and customary conditions.","Standard BioTools says merger accelerates path to profitability and strengthens capital structure.","Special meeting scheduled for January 4, 2024 at 12:00 p.m. ET (9:00 a.m. PT)."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-23-128923","json":"https://secwatch.observer/filing/0001104659-23-128923.json","markdown":"https://secwatch.observer/filing/0001104659-23-128923.md","text":"https://secwatch.observer/filing/0001104659-23-128923.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1162194/000110465923128923/0001104659-23-128923-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1162194/000110465923128923/tm2333662d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T07:13:45.405895+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}